“…In pancreatic cancer, Porphyromonas gingivalis is the most studied, and data have shown in murine models that they are able to promote progression of pancreatic cancer ( Chen et al., 2020 ; Gnanasekaran et al., 2020 ; Hiraki et al., 2020 ). Other experimental data have shown that the P. gingivalis may invade and promote proliferation of other cancer types including oral squamous cell carcinoma ( Inaba et al., 2014 ; Geng et al., 2017 ; Chang et al., 2019 ; Hoppe et al., 2019 ; Yao et al., 2021 ), endothelial cancer ( Crooks et al., 2021 ), colorectal carcinoma ( Mu et al., 2020 ; Wang et al., 2021 ), oesophageal squamous cell carcinoma ( Meng et al., 2019 ; Liang et al., 2020 ; Chen et al., 2021 ), and head and neck cancer ( Utispan et al., 2018 ). Further, P. gingivalis has been shown to promote chemotherapy resistance to paclitaxel in oral squamous cell carcinoma ( Song et al., 2019 ).…”